Facebook
Instagram
Twitter
YouTube
RSS Feed
LinkedIn
Flickr
California Institute for Regenerative Medicine
For Researchers
FUNDING OPPORTUNITIES
Information for Applicants
All Funding Opportunities
COVID-19
Discovery
Translational
Clinical
Infrastructure
Education
Previous Funding Opportunities
GRANTS
Active Awards Portfolio Dashboard
CIRM Grants
Managing Your Grant
CIRM Grantees
CIRM-Funded Institutions
CIRM Funding Commitments
Stem Cell Grant Regulations
CLINICAL RESOURCES
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Cell and Gene Therapy Center
Collaborative Funding Partnerships
RESEARCH RESOURCES
FAQs for CIRM Awards
Industry Alliance Program
iPSC Repository
Genomics Initiative
CIRM Publications
Grantee Publications
Webinars and Workshops
hESC Cell Lines
For Patients
Patient Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Stem Cell Champions
Disease Programs
Stories of Hope
CIRM Stem Cellar Blog
Stem Cell Videos
Stem Cell Basics
Stem Cell Key Terms
Creating New Types of Stem Cells
Accelerating Research Towards Cures
California: The Leader in Stem Cell Research
From Lab Bench to Bedside
Myths and Misconceptions About Stem Cell Research
Stem Cell Tourism
The Power of Stem Cells
Patient Toolbox
Get Involved
Talking About CIRM
Jargon-Free Glossary
Media Interviews
Delivering the Perfect Presentation
Moderating a Panel
Serving on a Panel
Participating in Clinical Trials
Our Impact
Impact
Active Awards Dashboard
Funding Clinical Trials
Return on Investment
Creating Jobs
Creating Infrastructure
Growing the Field
Strategic Plan
Education
Internship programs (Bridges & SPARK)
Education Portal
Training Tomorrow's Scientists
Community
Stem Cell Champions
Stem Cell Awareness Day
Get Involved
About CIRM
About Us
Our Mission
Executive Team
CIRM Team Leads
Our History
2024 Annual Report
CIRM FAQ
Where CIRM funding goes
Job Opportunities
Contact Us
Governing Board
Public Meetings
CIRM Resources
Annual Report Archive
Strategic Plan
Funding Opportunities
Administrative Policies and Forms
News and Events
Newsroom
Meetings & Events
Public Meetings and Events
CIRM Board Meetings
Blog
Multimedia Resources
Podcast
Videos
Images
CIRM Fact Sheet
Logos
Contact Us
All CIRM Grants
Search Filters »
Disease Focus
(All)
aa Multiple Diseases (Centers & Resoures) (14)
Age-related macular degeneration (13)
Aging (22)
Alpha Thalassemia Major (3)
Alzheimer's Disease (35)
Amyotrophic Lateral Sclerosis (59)
Anemia (10)
Angelman Syndrome (1)
Arthritis (14)
Autism (23)
Autoimmune Disorder (1)
B cell cancers (12)
Beta Thalassemia (5)
Bladder or Urinary Tract Disorder (6)
Blood Cancer (73)
Blood Disorders (114)
Bone Marrow Transplant and Viral Infection (7)
Bone or Cartilage Disease (52)
Brain Cancer (35)
Brain Injury, hypoxic, ischemic (2)
Breast Cancer (9)
Canavan Disease (1)
Cancer (167)
Cartilage defect (4)
Colon Cancer (6)
Corneal Damage (7)
COVID-19 (23)
Cystic Fibrosis (3)
Cystinosis (3)
Danon Disease (4)
Dementia (5)
Developmental Disorders (23)
Diabetes (53)
Diabetic Wounds (2)
Duchenne Muscular Dystrophy (4)
Epidermolysis Bullosa (3)
Epilepsy (12)
Fertility (13)
Genetic Disorder (41)
Hearing Loss (11)
Heart Disease (105)
Heart disease associated with Duchenne muscular dystrophy (2)
Heart failure (12)
Hemophilia A (2)
HIV-related Lymphoma (2)
HIV/AIDS (42)
Huntington's Disease (37)
Hyper IgM Syndrome (2)
Hypertension, pulmonary arterial (2)
Immune Disease (57)
Incontinence (2)
Infectious Disease (55)
Inflammatory bowel disease (1)
Intellectual Disability (5)
Intervertebral disc degeneration (2)
Intestinal Disease (16)
IPEX Syndrome (5)
Kidney Disease (17)
Kidney Failure (14)
Leukemia (10)
Leukemia, Acute Myeloid (AML) (23)
Leukocyte Adhesion Deficiency (2)
Liver Disease (22)
Lung Cancer (6)
Lung Disease, Fibrosis (5)
Lupus, Systemic Lupus Erythematosus (SLE) (2)
Melanoma (13)
Metabolic Disorders (89)
Multiple Myeloma (8)
Multiple Sclerosis (9)
Muscle Injury (3)
Muscular Dystrophy (25)
N/A (441)
Neurological Disorders (311)
Neuropathy (5)
Osteoarthritis (6)
Osteonecrosis (3)
Other (19)
Ovarian Cancer (9)
Pancreatic Cancer (4)
Parkinson's Disease (52)
Pediatrics (74)
Prostate Cancer (7)
Pulmonary Hypertension (4)
Respiratory Disorders (28)
Retinitis Pigmentosa (11)
Rett's Syndrome (7)
Sanfilippo Syndrome/MPS III (2)
Sarcoma (4)
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) (4)
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) (4)
Severe Combined Immunodeficiency, X-linked (X-SCID) (8)
Sickle Cell Disease (23)
Skeletal/Smooth Muscle disorders (45)
Skin cancer (2)
Skin Disease (19)
Solid Tumors (93)
Spina Bifida (5)
Spinal Cord Injury (42)
Spinal Muscular Atrophy (9)
Stroke (29)
Tendon/Ligament/Connective Tissue Injury or Disorder (3)
Thymic Disorder, 22q11 Deletion/DiGeorge (1)
Toxicity (7)
Trauma (10)
Traumatic Brain Injury (5)
Type 1 diabetes (21)
Vascular Disease (17)
Vision Loss (66)
Wounds, ulcers (3)
X-linked Chronic Granulomatous Disease (3)
Zika virus (3)
Institution
(All)
AcuraStem Incorporated (2)
Adjuvant Partners, LLC (1)
Adverum Biotechnologies (1)
Ali Nsair (1)
Alliance Forum Foundation (4)
Allogene Therapeutics (1)
Alto Neuroscience (1)
American Association of Blood Banks (2)
American Institute of Chemical Engineers (AIChE) (1)
Angiocrine Bioscience, Inc. (4)
Ankasa Regenerative Therapeutics, Inc. (2)
Aspen Neuroscience (2)
Aspera Biomedicines, Inc. (1)
Axent Biosciences Inc. (1)
Benjamin D. Yu (1)
Berkeley City College (2)
Biocom Institute (1)
BioEclipse Therapeutics INC. (1)
Biomedical Engineering Society (2)
BioTime, Inc. (1)
Bluebird Bio (1)
Boston Children’s Hospital (1)
Brain Mapping Foundation (2)
Brain Neurotherapy Bio (1)
BrainStorm Cell Therapeutics (1)
BrainXell Therapeutics (2)
Buck Institute for Age Research (9)
Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo (4)
Cal Poly Pomona Foundation (1)
Cal State Univ, Fullerton (4)
Cal State Univ, Long Beach (3)
Cal State Univ, Sacramento (3)
Cal State Univ, San Bernadino (4)
Caladrius Biosciences (2)
Calibr (3)
Calidi Biotherapeutics, Inc. (1)
California Institute of Technology (5)
California State University San Marcos Corporation (7)
California State University, Channel Islands (3)
Calimmune, Inc. (1)
Capricor, Inc (2)
Cedars-Sinai Medical Center (45)
Cellerant Therapeutics, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Cellular Dynamics International (1)
Celularity Inc. (1)
Chardan (1)
Charles R. Drew University of Medicine and Science (1)
Children’s Hospital of Los Angeles (18)
Children’s Hospital of Orange County (2)
Children’s Neurobiological Solutions (CNS) Foundation (1)
City College Of San Francisco (3)
City of Hope, Beckman Research Institute (59)
Combangio, Inc. (1)
Cytonus Therapeutics, Inc. (1)
Defined Bioscience, Inc. (1)
Elpida Therapeutics (1)
Escape Therapeutics, Inc (1)
Eureka Therapeutics, Inc. (1)
EVERSANA (1)
ExCellThera Inc. (1)
Excision BioTherapeutics (1)
Fate Therapeutics, Inc. (2)
Fluidigm Corporation (2)
Forty Seven Inc. (2)
FUJIFILM Cellular Dynamics (1)
Gamma Medica-Ideas, Inc. (1)
Genascence Corporation (1)
Geron Corporation (2)
Gladstone Institutes, J. David (39)
Global Genes (1)
GMR Epigenetics (1)
Gordon Research Conferences (3)
Greenstone Biosciences, Inc. (3)
HEALIOS NA, Inc. (1)
Humacyte, Inc. (2)
Human BioMolecular Research Institute (4)
Human Organ Project (1)
Humboldt State University Sponsored Programs Foundation (4)
ImmPACT-Bio, Inc. (1)
Immune-Onc Therapeutics (1)
ImmunoCellular Therapeutics (1)
ImmunoVec (3)
Immusoft Corporation (2)
Int. Soc. for Cell Gene Ther. (1)
Intact Therapeutics, Inc. (1)
International Alliance for Biological Standardization (1)
International Society for Experimental Hematology (1)
International Society for Stem Cell Research (6)
International Symposium on Neural Regeneration, Inc. (1)
iPierian, Inc. (2)
IQVIA, Inc. (2)
Jackson Labs (1)
Jasper Therapeutics, Inc. (1)
jCyte, Inc (2)
JDRF International (2)
Juvena Therapeutics Inc. (1)
Kenai Therapeutics (1)
Keystone Symposia on Molecular and Cellular Biology (3)
La Jolla Institute for Allergy and Immunology (1)
Lineage Cell Therapeutics, Inc. (3)
Loma Linda University (2)
Ludwig Institute for Cancer Research (3)
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center (5)
Luxa Biotechnology (1)
Mahzi Therapeutics (2)
MAX BioPharma, Inc. (1)
Medeor Acquisition Corp. (1)
Midwinter Conference of Immunologists (3)
Minutia, Inc. (2)
MiraCosta College (1)
Mohammad Pashmforoush (1)
Mosaic Event Management, Inc. (1)
MyoGene Bio LLC (1)
Nammi Therapeutics, Inc. (1)
Nanotools Bioscience (1)
Navega Therapeutics (1)
Neurona Therapeutics (5)
Nexcella, Inc. (1)
Nohla Therapeutics Inc (1)
Novoglia, Inc. (2)
Numerate, Inc. (1)
OCTANe Foundation for Innovation (1)
Ocular Research Symposia Foundation, Inc. (1)
OncoMed Pharmaceuticals, Inc. (1)
Orchard Therapeutics plc (1)
Organos, Inc. (1)
Ossium Health, Inc. (1)
Palo Alto Veterans Institute for Research (6)
Parkinson’s Institute (5)
Pasadena City College (3)
Pathways to Stem Cell Science (1)
Poseida Therapeutics, Inc. (2)
Rampart Bioscience (1)
RARE-X (1)
Ray Therapeutics, INC (2)
Regencor, Inc. (1)
Regenerative Patch Technologies LLC (1)
Rejuvenate Bio (1)
Rejuvenation Technologies, Inc. (1)
Replay Holdings, Inc (1)
Research for Cure (1)
Reza Ardehali (1)
Rocket Pharmaceuticals, Inc. (3)
Rubedo Life Sciences Inc. (1)
Rumi Scientific CA (1)
RUNX1 Research Program (1)
Salk Institute for Biological Studies (25)
Samumed, LLC (1)
San Diego State University Foundation (5)
San Francisco State University (4)
SanBio, Inc. (1)
Sanford Burnham Prebys Medical Discovery Institute (28)
Sanford Consortium for Regenerative Medicine (8)
Sangamo BioSciences, Inc. (2)
Scaled Biolabs Inc. (1)
Scripps Health (5)
Scripps Research Institute (31)
Semma Therapeutics (1)
Senti Biosciences, Inc. (1)
Siren Biotechnology, Inc. (1)
SJSU Research Foundation (3)
Solano Community College (1)
St. Jude Children’s Research Hospital (1)
Stanford University (179)
StemCells, Inc. (3)
Summit for Stem Cell Foundation (1)
SynGAP Research Fund (1)
Tachyon Therapeutics, Inc (1)
Tenaya Therapeutics, Inc. (1)
The American Society of Gene & Cell Therapy (1)
The Biomedical Engineering Society (1)
The Regents of the University of California on behalf of its Riverside Campus (11)
The Scintillon Institute (2)
The Stone Research Foundation for Sports Medicine and Arthritis (1)
The University Corporation at California State University, Northridge (4)
Tippi C. Mackenzie (1)
Tr1X Inc. (1)
TriFoil Imaging, Inc. (1)
UCSF Benioff Children’s Hospital Oakland (8)
University of California, Berkeley (34)
University of California, Davis (77)
University of California, Irvine (72)
University of California, Los Angeles (163)
University of California, Merced (8)
University of California, San Diego (139)
University of California, San Francisco (125)
University of California, Santa Barbara (14)
University of California, Santa Cruz (16)
University of Southern California (53)
Vala Sciences, Inc. (1)
Vertuis Bio, Inc. (1)
ViaCyte, Inc. (9)
VistaGen Therapeutics, Inc. (1)
Vitabolus, Inc. (1)
Vitalant Research Institute (6)
VxBiosciences inc. (1)
Wake Forest University Health Sciences (1)
Western University of Health Sciences (1)
X-Therma Inc. (1)
Zenobia Therapeutics (1)
Program Type
(All)
Clinical (172)
Discovery (723)
Education (326)
Infrastructure (104)
Translation (156)
Grant Type
(All)
Accelerated Development Pathway I (1)
Accelerating Center (1)
Alpha Stem Cell Clinics (3)
Alpha Stem Cell Clinics Network Expansion (12)
Basic Biology I (12)
Basic Biology II (16)
Basic Biology III (27)
Basic Biology IV (28)
Basic Biology V (28)
Bridges (16)
Bridges (29)
Clinical Trial Stage Projects (3)
Clinical Trial Stage Projects (92)
COMPASS Training Grant (16)
Comprehensive Grant (29)
Conference (81)
Conference – 2024 CIRM Trainee Network Conference (1)
Conference – Lung Regenerative Medicine Workshop (1)
Conference – Manage a Symposium on Pluripotent Stem Cell Manufacturing (1)
Conference – Manage The 2016 Bridges And SPARK Annual Meetings (1)
Conference – Manage The Bridges Annual Meeting (4)
Conference – Manage The SPARK Annual Meeting (7)
Conference – The 2016 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2017 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2018 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2019 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The Alpha Stem Cell Clinic Annual Symposium (2)
Conference – The 2020 Grantee Meeting (1)
Conference II (84)
Creativity Awards (9)
Cure Sickle Cell Initiative Clinical Trial Stage Projects (3)
Diagnostic Translational Research Projects (3)
Discovery Research Projects (12)
Discovery Research Projects (1)
Disease Team Planning (22)
Disease Team Research I (15)
Disease Team Therapy Development – Research (12)
Disease Team Therapy Development III (6)
Disease Team Therapy Planning I (19)
Early Translational from Disease Team Conversion (3)
Early Translational I (16)
Early Translational II (24)
Early Translational III (21)
Early Translational IV (14)
Foundation – Discovery Stage Research Projects (39)
Genomics Centers of Excellence Awards (R) (3)
hiPSC Derivation (1)
hPSC Repository (1)
Inception – Discovery Stage Research Projects (39)
iPSC Consortia Award (1)
Late Stage Preclinical Projects (49)
Major Facilities (12)
Manufacturing Network Grant (9)
Medical Device Translational Research Projects (1)
New Cell Lines (18)
New Faculty I (26)
New Faculty II (24)
New Faculty Physician Scientist (15)
Patent Assistance Fund Awards (8)
Preclinical Development Awards (7)
Progression Award – Discovery Stage Research Projects (8)
Quest – Discovery Stage Research Projects (144)
ReMIND – Discovery Stage ReMIND (5)
Research Leadership (14)
Research Training Grant (18)
Research Training II (17)
SEED Grant (74)
Shared Labs (34)
SPARK (18)
Strategic Partnership I (2)
Strategic Partnership II (1)
Strategic Partnership III Track A (2)
Targeted Clinical Development (1)
Therapeutic Translational Research Projects (81)
Therapeutic Translational Research Projects (1)
Tissue Collection for Disease Modeling (7)
Tool Translational Research Projects (7)
Tools and Technologies I (23)
Tools and Technologies II (20)
Tools and Technologies III (22)
Training Grant I-1 (8)
Training Grant I-2 (5)
Training Grant I-3 (3)
Translating Center (1)
Transplantation Immunology (20)
Human Stem Cell Use
(All)
Adult or Tissue Stem Cell (318)
Cancer Stem Cell (46)
Directly Reprogrammed Cell (11)
Embryonic Stem Cell (389)
iPS Cell (303)
N/A (405)
Other (11)
SCNT (2)
Somatic Cell (30)
Vital Research Opportunity (3)
Cell Line Generation
(All)
Adult or Tissue Stem Cell (61)
Cancer Stem Cell (12)
Directly Reprogrammed Cell (2)
Embryonic Stem Cell (52)
iPS Cell (133)
N/A (1048)
Other (9)
SCNT (2)
Collaborative Funder
(All)
Andalusia, Spain (1)
Australia (3)
Canada (2)
France (1)
Germany (10)
Japan (1)
NIH (3)
United Kingdom (3)
Victoria, Australia (6)
Award Status
(All)
Active (348)
Closed (1115)
Pre-Active (18)
Institution
Researcher name
Grant Type
Grant Title
Award Value
Stanford University
Dr. Theo D. Palmer PhD
Tools and Technologies II
Development of small molecule screens for autism using patient-derived iPS cells
$1,797,606
University of California, Berkeley
Dr. Steven M. Conolly
Tools and Technologies II
Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner for Tracking Stem Cells In Vivo
$1,311,596
University of California, San Diego
Shu Chien
Tools and Technologies II
Development of Synthetic Microenvironments for Stem Cell Growth and Differentiation
$1,706,628
University of California, Los Angeles
Dr. Thomas Carmichael M.D., Ph.D.
Tools and Technologies II
Development of a Hydrogel Matrix for Stem Cell Growth and Neural Repair after Stroke
$1,825,613
Stanford University
Dr. Michele Calos
Tools and Technologies II
Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation
$1,592,897
Fluidigm Corporation
Dr. Marc A Unger
Tools and Technologies II
Development and Application of Versatile, Automated, Microfluidic Cell Culture System
$1,939,236
University of California, Los Angeles
Dr. Martin Gabriel Martin
Tools and Technologies II
Pluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders
$1,783,250
University of California, Los Angeles
Dr. Sophie X Deng
Early Translational II
Regeneration of Functional Human Corneal Epithelial Progenitor Cells
$697,507
University of California, San Francisco
Dr. Arturo Alvarez-Buylla
Early Translational II
Inhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy
$1,564,016
University of California, Davis
Dr. Mark Zern
Early Translational II
Liver Cell Transplantation
$4,212,621
Stanford University
Dr. Michele Calos
Early Translational II
Stem Cell Therapy for Duchenne Muscular Dystrophy
$2,267,261
University of California, Irvine
Dr. Brian J. Cummings
Early Translational II
Neural restricted, FAC-sorted, human neural stem cells to treat traumatic brain injury
$1,517,767
University of California, Los Angeles
Dr. Sophie X Deng
Early Translational II
Regeneration of Functional Human Corneal Epithelial Progenitor Cells
$1,524,947
Cedars-Sinai Medical Center
Dr. Dan Gazit
Early Translational II
Systemic Adult Stem Cell Therapy for Osteoporosis-Related Vertebral Compression Fractures
$1,927,698
University of California, Los Angeles
Leif Havton
Early Translational II
Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons
$75,628
University of California, Irvine
Leif A Havton
Early Translational II
Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons
$1,527,011
City of Hope, Beckman Research Institute
Dr. Yanhong Shi Ph.D.
Early Translational II
Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell
$1,835,983
City of Hope, Beckman Research Institute
Dr. David Louis DiGiusto
Early Translational II
Development of RNA-based approaches to stem cell gene therapy for HIV
$3,097,160
University of California, Davis
Dr. Roslyn Rivkah Isseroff
Early Translational II
Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds
$4,629,747
University of California, Los Angeles
Dr. Noriyuki Kasahara
Early Translational II
Stem cell-based carriers for RCR vector delivery to glioblastoma
$3,340,625
Salk Institute for Biological Studies
Dr. Fred H Gage
Early Translational II
Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model
$2,472,839
University of California, Irvine
Dr. Henry John Klassen
Early Translational II
Human retinal progenitor cells as candidate therapy for retinitis pigmentosa
$1,803,768
Children’s Hospital of Los Angeles
Dr. Markus Muschen
Early Translational II
Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication
$850,769
University of California, San Francisco
Markus Muschen
Early Translational II
Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication
$2,756,536
Buck Institute for Age Research
Dr. Xianmin Zeng
Early Translational II
Banking transplant ready dopaminergic neurons using a scalable process
$4,983,013
iPierian, Inc.
Dr. John Dimos
Early Translational II
New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells
$2,410,000
University of California, Los Angeles
Prof. Bruno Peault
Early Translational II
Harnessing native fat-residing stem cells for bone regeneration
$5,359,076
Scripps Research Institute
Peter G. Schultz
Early Translational II
Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis
$6,047,249
University of California, San Diego
Professor Alysson R Muotri
Early Translational II
Developing a drug-screening system for Autism Spectrum Disorders using human neurons
$1,376,198
University of California, Irvine
Dr. Leslie M Thompson
Early Translational II
A hESc-based Development Candidate for Huntington’s Disease
$3,955,038
University of California, San Diego
Catriona Jamieson
Early Translational II
Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy
$3,103,041
Gladstone Institutes, J. David
Dr. Todd C. McDevitt
Research Leadership
Engineering microscale tissue constructs from human pluripotent stem cells
$5,849,100
University of California, Los Angeles
Dr. John P Chute
Research Leadership
Niche-Focused Research: Discovery & Development of Hematopoietic Regenerative Factors
$4,645,297
University of California, Berkeley
Dr. Xavier Darzacq
Research Leadership
Single Molecule Biophysics and Biology of Cellular Identity
$4,175,924
University of California, San Francisco
Redacted
Research Leadership
Recapitulating development of the musculoskeletal axis in vitro with pluripotent cells
$0
University of California, San Diego
Dr. Eric T. Ahrens
Research Leadership
Molecular Imaging for Stem Cell Science and Clinical Application
$5,680,474
University of California, Santa Cruz
Professor Richard Gregory
Research Leadership
MicroRNA Regulation in Stem Cells, Development, and Disease
$0
Stanford University
Professor Hiromitsu Nakauchi
Research Leadership
Generation of functional cells and organs from iPSCs
$5,426,135
Gladstone Institutes, J. David
Dr. Kevin Kit Parker PhD
Research Leadership
Engineering Cardiac Tissue for Regeneration and Drug Development
$0
Cedars-Sinai Medical Center
Dr. Barry R Stripp
Research Leadership
Epithelial progenitors and the stromal niche as therapeutic targets in lung disease
$4,841,830
Parkinson’s Institute
Dennis Steindler
Research Leadership
Stem Cell Pathologies in Parkinson’s disease as a key to Regenerative Strategies
$0
University of Southern California
Dr. Andrew McMahon
Research Leadership
Repair and regeneration of the nephron
$5,672,206
University of California, Berkeley
Dr. Zhigang He
Research Leadership
Developing a regeneration-based functional restoration treatment for spinal cord injury
$0
University of California, Santa Barbara
Professor Peter J Coffey
Research Leadership
Development of Cellular Therapies for Retinal Disease
$4,690,963
Sanford Burnham Prebys Medical Discovery Institute
Dr. Robert J Wechsler-Reya
Research Leadership
The role of neural stem cells in cerebellar development, regeneration and tumorigenesis
$5,226,049
Mohammad Pashmforoush
Dr. Mohammad Pashmforoush
New Faculty I
Medical School Loan Repayment Program
$27,949
Salk Institute for Biological Studies
Dr. Dana Leanne Jones
New Faculty I
Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity
$2,134,100
University of California, Los Angeles
Dr. Dana Leanne Jones
New Faculty I
Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity
$382,773
University of California, Los Angeles
Dr. Siavash Kurdistani
New Faculty I
Epigenetics in cancer stem cell initiation and clinical outcome prediction
$3,063,450
University of California, Santa Cruz
Dr. Camilla Forsberg
New Faculty I
Mechanisms of Stem Cell Fate Decisions
$2,201,759
« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
…
30
Next »